Atıf Formatları
Prognosis and predictor factors of anti HBs seroconversion following HBsAg seroclearance in hepatitis B infection
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. YAPALI Et Al. , "Prognosis and predictor factors of anti HBs seroconversion following HBsAg seroclearance in hepatitis B infection," The Liver Meeting 2011 (AASLD) , vol.54, United States Of America, pp.613, 2011

YAPALI, S. Et Al. 2011. Prognosis and predictor factors of anti HBs seroconversion following HBsAg seroclearance in hepatitis B infection. The Liver Meeting 2011 (AASLD) , (United States Of America), 613.

YAPALI, S., VARDAR, R., GÜNŞAR, F., ERSÖZ, G., KARASU, A. Z., & AKARCA, U. S., (2011). Prognosis and predictor factors of anti HBs seroconversion following HBsAg seroclearance in hepatitis B infection . The Liver Meeting 2011 (AASLD) (pp.613). , United States Of America

YAPALI, Suna Et Al. "Prognosis and predictor factors of anti HBs seroconversion following HBsAg seroclearance in hepatitis B infection," The Liver Meeting 2011 (AASLD), United States Of America, 2011

YAPALI, Suna Et Al. "Prognosis and predictor factors of anti HBs seroconversion following HBsAg seroclearance in hepatitis B infection." The Liver Meeting 2011 (AASLD) , United States Of America, pp.613, 2011

YAPALI, S. Et Al. (2011) . "Prognosis and predictor factors of anti HBs seroconversion following HBsAg seroclearance in hepatitis B infection." The Liver Meeting 2011 (AASLD) , United States Of America, p.613.

@conferencepaper{conferencepaper, author={Suna YAPALI Et Al. }, title={Prognosis and predictor factors of anti HBs seroconversion following HBsAg seroclearance in hepatitis B infection}, congress name={The Liver Meeting 2011 (AASLD)}, city={}, country={United States Of America}, year={2011}, pages={613} }